Soleus Capital Management, L.P. Acadia Pharmaceuticals Inc Transaction History

Soleus Capital Management, L.P.

  • $1.18 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$20.84 - $33.47 $3.72 Million - $5.98 Million
178,627 Added 270.65%
244,627 $5.1 Million
Q2 2023

Aug 14, 2023
SELL
$17.8 - $25.65 $2.21 Million - $3.18 Million
-124,000 Reduced 65.26%
66,000 $1.58 Million
Q1 2023

May 15, 2023
BUY
$16.32 - $20.92 $3.1 Million - $3.97 Million
190,000 New
190,000 $3.58 Million

Others Institutions Holding ACAD

# of Institutions
279
Shares Held
156M
Call Options Held
901K
Put Options Held
314K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Soleus Capital Management, L.P. Portfolio

Follow Soleus Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email